Compare Virgin Galactic Holdings, Inc. (SPCE) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Virgin Galactic Holdings, Inc. vs Tenet Healthcare Corporation — how do they compare? Virgin Galactic Holdings, Inc. trades at $2.84 (market cap $445.69M), while Tenet Healthcare Corporation trades at $263.45 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 47.1× Virgin Galactic Holdings, Inc.'s market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Virgin Galactic Holdings, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Virgin Galactic Holdings, Inc. for 69 Days and Tenet Healthcare Corporation for 15 Days on average.
| SPCE | THC | |
|---|---|---|
Market Cap | $445.69M | $20.98B |
Volume | 5,128,850 | 428,008 |
Sector | Industrials | Health |
52-Week High | $7.52 | $280.77 |
52-Week Low | $2.17 | $161.37 |
Typical Hold Time | 69 Days | 15 Days |
Enterprise Value | $409.68M | $32.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Virgin Galactic (SPCE) trades at $2.84, down 5.65% on the day, reflecting ongoing volatility amid a bearish technical signal. The company continues to report significant losses with a net income margin of -23,867.44% (2025 financials), though it has beaten EPS estimates in recent quarters. Cash flow remains negative, but the trend is improving, with management targeting positive quarterly cash flow by 2027. Recent news highlights strong ticket demand but also a delay in commercial Delta flights to February 2027.
The outlook remains high-risk due to persistent losses and cash burn, but long-term potential exists in commercial spaceflight. Investment opportunity hinges on successful execution of the Delta program and achieving profitability targets. Key risks include execution delays, high cash burn, competitive pressures, and stock dilution. Analyst sentiment is mixed, with 29.41% buy ratings, reflecting cautious optimism amid substantial operational challenges.
Tenet Healthcare (THC) trades at $263.78, up 1.52% today, with a bullish technical signal from moving averages and strong fundamental support. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 29, 2026. Revenue grew to $21.31B in 2025, with a robust net income margin of 9.9% and high return on equity of 53.31%, while valuation ratios like P/E of 10.07 and EV/EBITDA of 5.75 suggest potential undervaluation.
The outlook is positive, driven by earnings momentum and analyst consensus favoring buys, with a price target of $283.36 offering upside. Risks include reliance on surgical volumes and capital return sustainability, but strong cash flow and efficiency gains support growth. Investors should weigh solid fundamentals against sector-specific headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
